Thus, restoration of WT p53 function at least partially sensitized pancreatic tumor cells to MEK inhibition; however, expression of the specific Trp53R270H mutant did not change response to combined MEK and PI3K inhibition, compared with other pancreatic cancer cell lines. This evidence concerns the gene MAP2K7 and familial pancreatic carcinoma.